1. Home
  2. LPA vs CGEN Comparison

LPA vs CGEN Comparison

Compare LPA & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • CGEN
  • Stock Information
  • Founded
  • LPA 2013
  • CGEN 1993
  • Country
  • LPA United States
  • CGEN Israel
  • Employees
  • LPA N/A
  • CGEN N/A
  • Industry
  • LPA
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LPA
  • CGEN Health Care
  • Exchange
  • LPA Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • LPA 196.1M
  • CGEN 167.4M
  • IPO Year
  • LPA N/A
  • CGEN 2000
  • Fundamental
  • Price
  • LPA $6.03
  • CGEN $1.51
  • Analyst Decision
  • LPA
  • CGEN
  • Analyst Count
  • LPA 0
  • CGEN 0
  • Target Price
  • LPA N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • LPA 11.9K
  • CGEN 247.7K
  • Earning Date
  • LPA 08-13-2025
  • CGEN 08-06-2025
  • Dividend Yield
  • LPA N/A
  • CGEN N/A
  • EPS Growth
  • LPA N/A
  • CGEN N/A
  • EPS
  • LPA 0.57
  • CGEN N/A
  • Revenue
  • LPA $45,218,701.00
  • CGEN $27,589,000.00
  • Revenue This Year
  • LPA N/A
  • CGEN N/A
  • Revenue Next Year
  • LPA N/A
  • CGEN $105.77
  • P/E Ratio
  • LPA $11.02
  • CGEN N/A
  • Revenue Growth
  • LPA 7.03
  • CGEN N/A
  • 52 Week Low
  • LPA $5.90
  • CGEN $1.13
  • 52 Week High
  • LPA $15.85
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • LPA N/A
  • CGEN 42.88
  • Support Level
  • LPA N/A
  • CGEN $1.35
  • Resistance Level
  • LPA N/A
  • CGEN $1.50
  • Average True Range (ATR)
  • LPA 0.00
  • CGEN 0.06
  • MACD
  • LPA 0.00
  • CGEN -0.00
  • Stochastic Oscillator
  • LPA 0.00
  • CGEN 48.28

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: